How to manage Atrial Fibrillation
Atrial fibrillation (AF) is a common condition in which the upper chambers of the heart, or atria, fibrillate. This means that they beat very fast and irregularly so the heart can’t pump blood effectively to the rest of the body. People with AF are nearly 5 times more likely to have a stroke than someone who doesn’t have AF.1
Normal Heartbeat
A small pulse of electric current spreads quickly through the heart to make the muscle contract.
Atrial Fibrillation
In atrial fibrillation, the heart’s upper chambers quiver faster than the rest of the heart.
If you have AF, or your doctor suspects that you do, cardiac monitoring may be necessary to determine how often and how long it occurs. Sometimes episodes of AF are infrequent and require longer-term monitoring and, in some cases, your doctor may also want to monitor how effective different treatments are at keeping your AF under control.
WHY LONG-TERM MONITORING MAY BE RIGHT FOR YOU
Accurate information is the key to better heathcare. Irregular heartbeats may occur infrequently, making the underlying condition hard to find and treat. Now, there’s a way. With continuous, long-term monitoring, your doctor can get information about your heart to help find the right answer for you.
Reveal Linq ICM for long-term monitoring
The Reveal LINQ™ insertable cardiac monitor (ICM) provides data to your doctor that helps:
- Guide therapy decisions
- Assess symptom and rhythm correlation
- Know when treatments to manage your AF are working
Continuous Monitoring
Up to 3 years of cardiac monitoring2
The Reveal LINQ system includes a small insertable cardiac monitor that continuously monitors your heart, records irregular heart rhythms, and provides data to your doctor through a bedside transmitter called the MyCareLink™ Patient Monitor.
Simple
Insertion procedure is minimally invasive and brief
Convenient
100% of patients found Reveal LINQ ICM did not limit their activities of daily living3
Small
One-third the size of a AAA battery (1.2 cc)
MRI Conditional
Safe for MRI at 1.5 and 3.0T, even on the same day of insertion*
Reveal LINQ ICM has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use. Please see the Reveal™ ICM clinician manual or MRI technical manual for more details.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. August 1991;22(8):983-988.
Reference the Reveal LINQ ICM Clinician Manual for usage parameters.
Reveal LINQ Usability study. Medtronic data on file. 2013.